AstraZeneca Plans Full US listing, But Defuses Fears Of UK Exit

AstraZeneca laid out plans on Monday to directly list its shares in the United States, as the drugmaker seeks to maximise gains from its biggest market and investor pool, even as it said that it was not exiting London.